RecensMedical Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Revenue	8,829	6,259	5,771	281.76
Other Revenue	-	-	-0	-
Revenue	8,829	6,259	5,771	281.76
Revenue Growth (YoY)	41.05%	8.47%	1948.03%	-
Cost of Revenue	4,519	4,916	2,765	189.86
Gross Profit	4,309	1,343	3,006	91.91
Selling, General & Admin	10,701	10,993	12,079	17,019
Research & Development	3,410	2,422	2,836	2,867
Amortization of Goodwill & Intangibles	53.33	47.46	46.11	25.81
Other Operating Expenses	151.63	103.59	80.96	119.79
Operating Expenses	14,950	15,504	15,590	20,337
Operating Income	-10,640	-14,161	-12,584	-20,245
Interest Expense	-2,408	-3,897	-3,064	-2,206
Interest & Investment Income	107.08	33.27	162.3	113.82
Currency Exchange Gain (Loss)	-6.28	132.5	53.29	457.5
Other Non Operating Income (Expenses)	-6,172	10,049	7,926	-19,115
EBT Excluding Unusual Items	-19,119	-7,844	-7,506	-40,994
Gain (Loss) on Sale of Assets	-	-	-66.17	-
Pretax Income	-19,119	-7,844	-7,572	-40,994
Net Income	-19,119	-7,844	-7,572	-40,994
Net Income to Common	-19,119	-7,844	-7,572	-40,994
Shares Outstanding (Basic)	7	3	3	3
Shares Outstanding (Diluted)	7	3	3	3
Shares Change (YoY)	93.31%	3.17%	0.43%	-
EPS (Basic)	-2890.00	-2292.00	-2282.91	-12412.11
EPS (Diluted)	-2890.00	-2292.00	-2282.91	-12412.11
Free Cash Flow	-9,354	-10,215	-13,530	-22,740
Free Cash Flow Per Share	-1413.99	-2984.99	-4079.06	-6885.21
Gross Margin	48.81%	21.46%	52.09%	32.62%
Operating Margin	-120.52%	-226.24%	-218.07%	-7185.17%
Profit Margin	-216.56%	-125.31%	-131.22%	-14549.34%
Free Cash Flow Margin	-105.95%	-163.20%	-234.47%	-8070.77%
EBITDA	-10,130	-13,772	-12,059	-19,821
EBITDA Margin	-114.75%	-220.03%	-208.98%	-
D&A For EBITDA	509.91	388.72	524.36	424.46
EBIT	-10,640	-14,161	-12,584	-20,245
EBIT Margin	-120.52%	-226.24%	-218.07%	-
Advertising Expenses	1,436	2,081	2,007	1,008

Source: S&P Global Market Intelligence. Standard template. Financial Sources.